Back to Business

Windward Bio seeks Nasdaq listing to fund respiratory, skin disease drug trials

Business October 24, 2026 at 12:08 AM

Windward Bio seeks Nasdaq listing to fund respiratory, skin disease drug trials

Investing.com

Read the full story at Investing.com

More Stories

Therma Bright plans private placement of up to $420,000

Therma Bright plans private placement of up to $420,000

🇺🇸 Investing.com 45m ago

Russia, Ukraine agree to local ceasefire as new peace talks planned - Reuters

Russia, Ukraine agree to local ceasefire as new peace talks planned - Reuters

🇺🇸 Investing.com 48m ago

Goldcana closes C$1 million flow-through private placement

Goldcana closes C$1 million flow-through private placement

🇺🇸 Investing.com 53m ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play